active pharmaceutical ingredients and intermediates
-
Clinical studies have highlighted the benefits of LOLA in patients with chronic liver disease. For instance, several trials have demonstrated that LOLA treatment can lead to significant reductions in ammonia levels, accompanied by improvements in cognitive function and overall quality of life for patients suffering from hepatic encephalopathy. This therapeutic potential positions LOLA as a viable option for managing complications arising from chronic liver diseases, particularly in cases where standard treatments may be insufficient.
tab l ornithine l aspartate...
-
Isoflurane is also notable for its cardiovascular stability. It causes dose-dependent hypotension, and while it can affect heart rate, it generally preserves cardiac function better than most other volatile anesthetics. This property is particularly advantageous for patients with pre-existing cardiovascular conditions. Moreover, its use in a controlled environment allows anesthesiologists to manage blood pressure effectively through various supplemental agents.
isoflurane 100ml...